Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Long Term Clinical Results of Triple Valve Replacement

삼중 판막 대치술의 장기 결과

  • Yu, Song-Hyeon (Department of Thoracic & Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Hong, You-Sun (Department of Thoracic & Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Chang, Byung-Chul (Department of Thoracic & Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Kang, Meyun-Shick (Department of Thoracic & Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Lim, Sang-Hyun (Department of Thoracic & Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine)
  • 유송현 (연세대학교 의과대학 흉부외과학교실) ;
  • 홍유선 (연세대학교 의과대학 흉부외과학교실) ;
  • 장병철 (연세대학교 의과대학 흉부외과학교실) ;
  • 강면식 (연세대학교 의과대학 흉부외과학교실) ;
  • 임상현 (연세대학교 의과대학 흉부외과학교실)
  • Published : 2005.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Clinical reports on replacement of all three (AV + MV + TV) valves are rare. Material and Method: From January 1992 to December 2003, 38 patients received triple valve replacement (aortic, mitral, tricuspid) at Yonsei Cardiovascular Center. Mean age of patients was $49.5\pm10.7 (28\~69)$ years, and 24 patients $(63.1\%)$ were female. Rheumatic valve disease was the most common cause of operation (n=37). Preoperative New York Heart Association functional class were II in 4, III in 24 and IV in 10. Fifteen patients (group 1) received triple valve replacement at their first operation. Twenty three patients (group 2) received one or more operations before tricuspid valve replacement (TVR). Seven patients received tricuspid valve annuloplasty at first operation and received TVR later. Result: Six patients died at hospital after operation $(15.8\%)$ and all these patients were in group 2. All patients in group I survived and were discharged. Three patients $(9.4\%)$ died during follow up periods. Most of the survivors had improved functional class (I in 22, II in 8, III in 1, IV in 1). During follow up period, there were 4 valve related complications. The 10-year survival rate was $68.8\%$ and survival rate for free from valve related event at 10 years was $85.5\%$. Conclusion: After triple valve replacement, most patients showed improvement of symptoms. And during follow up period, valve related complications and survival were acceptable. Therefore, if indicated, triple valve replacement is recommended before the patients' conditions get worse.

배경: 삼중 판막 대치술의 임상적 결과에 대한 문헌들은 매우 드물다. 대랄 및 방법. 1992년 1월부터 2003년 12월까지 38명의 환자가 연세 심장혈관 병원에서 삼중 판막에 대한 대치술을 시행받았다. 평균 나이는 $49.5\pm10.7 (28\~69)$세였으며 24명이 여자였다. 류마치스성 심장 판막 질환이 가장 흔한 원인이었고(n=37), 수술 전 New York Heart Association (NYHA) functional class는 II가 4명, III가 24명, IV가 10명이었다. 15명의 환자는(group 1) 최초의 수술에서 삼중 판막 대치술을 시행 받은 경우였고, 23명의 환자는(group 2) 이전에 일회 이상의 심장 수술을 받았으며 한 명을 제외하고는 삼첨 판막 대치술을 제일 나중에 시행 받은 경우였다. 7명의 환자는 최초 수술에서 삼첨 판막 성형술을 받은 후 삼첨 판막 대치술을 시행 받은 환자들이었다. 걸과 수술 사망은 6명$(15.8\%)$이었으며 모두 group 2에 속하는 환자들이었다. 최초 수술에서 삼중 판막 대치술을 시행 받은 15명의 환자는 수술 사망 없이 모두 퇴원하였다. 평균 $66.0\pm40.7$개월의 추적 관찰 기간 중에 만기 사망은 3명$(9.4\%)$에서 있었으며 대부분의 환자에서 NYHA functional class의 향상을 보였다. 4명의 환자에서 인공 판막과 관련된 합병증이 있었으며, 10년 생존율은 $68.8\%$였고, 생존자에 있어서 재수술을 포함한 10년 무사고 생존율은 $85.5\%$였다. 결론: 삼중 판막 대치술 후에 대부분의 환자에서 증상의 호전을 보였다. 그리고 추적 관찰기간 중에 인공 판막과 관련된 합병증 발생 및 생존율은 만족할 만한 결과를 보였다. 따라서 적응이 되는 경우에는 환자의 상태가 더 나빠지기 전에 삼중 판막 대치술을 적극적으로 고려해야 할 것이다.

Keywords

References

  1. Brown PS Jr, Roberts CS, McIntosh CL, Swain JA, Clark RE. Late results after triple-valve replacement with various substitute valves. Ann Thorac Surg 1993;55:502-8 https://doi.org/10.1016/0003-4975(93)91028-L
  2. Michel PL, Houdart E, Ghanem G, Badaoui G, Hage A, Acar J. Combined aortic, mitral and tricuspid surgery: results in 78 patients. Eur Heart J 1987;8:457-63 https://doi.org/10.1093/eurheartj/8.suppl_J.457
  3. Gersh BJ, Schaff HV, Vatterott PJ, et al. Results of triple valve replacement in 91 patients: perioperative mortality and long term follow up. Circulation 1985;72:130-7 https://doi.org/10.1161/01.CIR.72.1.130
  4. Carrier M, Pellerin M, Bouchard D, et al. Long term results with triple valve surgery. Ann Thorac Surg 2002;73:44-7 https://doi.org/10.1016/S0003-4975(01)03304-5
  5. Yilmaz M, Ozkan M, Boke E. Triple valve surgery: a 25-year experience. Anadolu Kardiyol Derg 2004;4:205-8
  6. Kara M, Langlet MF, Blin D, et al. Triple valve procedures: an analysis of early and late results. Thorac Cardiovasc Surg 1986;34:17-21 https://doi.org/10.1055/s-2007-1020365
  7. Coll-Mazzei JV, Jegaden O, Janody P, Rumolo A, Bonnefoy JY, Mikaeloff P. Results of triple valve replacement: perioperative mortality and long term results. J Cardiovasc Surg 1987;28:369-73
  8. Tayama E, Kawano H, Takaseya T, et al. Triple valve replacement with bileaflet mechanical valves: is the mechanical valve the proper choice for the tricuspid position? Jpn Circ J 2001;65:257-60 https://doi.org/10.1253/jcj.65.257
  9. Kaplan M, Kut MS, Demirtas MM, Cimen S, Ozler A. Prosthetic replacement of tricuspid valve: bioprosthetic or mechanical. Ann Thorac Surg 2002;73:467-73 https://doi.org/10.1016/S0003-4975(01)03128-9
  10. Prabhakar G, Kumar N, Gometza B, Galal O, al-Halees Z, Duran CM. Triple valve operation in the young rheumatic patient. Ann Thorac Surg 1993;55:1492-6 https://doi.org/10.1016/0003-4975(93)91095-5